Autopsy report · NCT00186745

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

“Funding ceased”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months after it had already started.
• Ran for about 10 years 11 months before it stopped.
• 148 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

St. Joseph's Healthcare Hamilton

Sponsor type

University, hospital or other

Conditions

Venous Thrombosis; Pulmonary Embolism

Interventions

Tinzaparin

Participants

148

Sites

1

Countries

Canada

Trials that died the same way

• Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
  “Funding Stopped” (94% match in meaning)
• Clinical, Pharmacological and Molecular Effects of IV and Oral Acetaminophen in Adults With aSAH
  “Funding was stopped” (91% match in meaning)
• Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
  “Funding discontinued” (89% match in meaning)
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
  “no longer had funding to continue” (88% match in meaning)
• Evaluating Tumor Pseudoprogression With FLT-PET and MRI
  “Funding ended” (88% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.